XLV vs. DGS
XLV (State Street Health Care Select Sector SPDR ETF) and DGS (WisdomTree Emerging Markets SmallCap Dividend Fund) are both exchange-traded funds - XLV is a Health & Biotech Equities fund tracking the Health Care Select Sector Index, while DGS is a Emerging Markets Diversified fund tracking the WisdomTree Emerging Markets SmallCap Dividend Index. Both are passively managed. Over the past 10 years, XLV returned 9.81%/yr vs 10.14%/yr for DGS. A 0.52 correlation means they provide meaningful diversification when combined. XLV charges 0.08%/yr vs 0.58%/yr for DGS.
Performance
XLV vs. DGS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XLV achieves a -0.23% return, which is significantly lower than DGS's 14.94% return. Both investments have delivered pretty close results over the past 10 years, with XLV having a 9.81% annualized return and DGS not far ahead at 10.14%.
XLV
- 1D
- -0.18%
- 1M
- 4.90%
- YTD
- -0.23%
- 6M
- 0.67%
- 1Y
- 15.00%
- 3Y*
- 7.12%
- 5Y*
- 6.00%
- 10Y*
- 9.81%
DGS
- 1D
- 0.65%
- 1M
- 1.51%
- YTD
- 14.94%
- 6M
- 17.07%
- 1Y
- 25.61%
- 3Y*
- 15.36%
- 5Y*
- 8.06%
- 10Y*
- 10.14%
XLV vs. DGS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XLV State Street Health Care Select Sector SPDR ETF | -0.23% | 14.50% | 2.47% | 2.07% | -2.08% | 26.04% | 13.30% | 20.45% | 6.28% | 21.77% |
DGS WisdomTree Emerging Markets SmallCap Dividend Fund | 14.94% | 21.18% | 1.13% | 19.08% | -12.35% | 15.33% | 4.06% | 18.90% | -16.52% | 37.47% |
Correlation
The correlation between XLV and DGS is 0.32, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.32 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.32 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.38 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.44 |
Correlation (All Time) Calculated using the full available price history since Oct 30, 2007 | 0.52 |
Over the past year, the correlation between XLV and DGS has dropped to 0.32 - well below their long-term average of 0.52, suggesting their price drivers have been diverging.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XLV vs. DGS — Risk / Return Rank
XLV
DGS
XLV vs. DGS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for State Street Health Care Select Sector SPDR ETF (XLV) and WisdomTree Emerging Markets SmallCap Dividend Fund (DGS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XLV | DGS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.48 | ||
| Sortino ratioReturn per unit of downside risk | -0.47 | ||
| Omega ratioGain probability vs. loss probability | 1.17 | 1.27 | -0.09 |
| Calmar ratioReturn relative to maximum drawdown | 1.38 | 2.38 | -0.99 |
| Martin ratioReturn relative to average drawdown | 3.31 | 7.84 | -4.53 |
Loading charts...
Drawdowns
XLV vs. DGS - Drawdown Comparison
The maximum XLV drawdown since its inception was -39.17%, smaller than the maximum DGS drawdown of -61.83%. Use the drawdown chart below to compare losses from any high point for XLV and DGS.
Loading charts...
Drawdown Indicators
| XLV | DGS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -39.17% | -61.83% | +22.66% |
Max Drawdown (1Y)Largest decline over 1 year | -10.47% | -10.06% | -0.41% |
Max Drawdown (3Y)Largest decline over 3 years | -17.11% | -19.31% | +2.20% |
Max Drawdown (5Y)Largest decline over 5 years | -17.11% | -24.86% | +7.75% |
Max Drawdown (10Y)Largest decline over 10 years | -28.40% | -44.08% | +15.68% |
Current DrawdownCurrent decline from peak | -3.59% | -1.05% | -2.54% |
Average DrawdownAverage peak-to-trough decline | -7.12% | -12.57% | +5.45% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.37% | 3.05% | +1.32% |
Volatility
XLV vs. DGS - Volatility Comparison
The current volatility for State Street Health Care Select Sector SPDR ETF (XLV) is 4.90%, while WisdomTree Emerging Markets SmallCap Dividend Fund (DGS) has a volatility of 7.30%. This indicates that XLV experiences smaller price fluctuations and is considered to be less risky than DGS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XLV | DGS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.90% | 7.30% | -2.40% |
Volatility (6M)Calculated over the trailing 6-month period | 10.60% | 14.27% | -3.67% |
Volatility (1Y)Calculated over the trailing 1-year period | 15.03% | 16.60% | -1.57% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.75% | 15.08% | -0.33% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.58% | 17.39% | -0.81% |
XLV vs. DGS - Expense Ratio Comparison
XLV has a 0.08% expense ratio, which is lower than DGS's 0.58% expense ratio.
Dividends
XLV vs. DGS - Dividend Comparison
XLV's dividend yield for the trailing twelve months is around 1.63%, less than DGS's 3.20% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DGS WisdomTree Emerging Markets SmallCap Dividend Fund | 3.20% | 3.45% | 3.36% | 4.55% | 5.34% | 3.98% | 3.69% | 3.95% | 4.24% | 2.81% | 3.42% | 3.28% |
XLV State Street Health Care Select Sector SPDR ETF | 1.63% | 1.60% | 1.67% | 1.59% | 1.47% | 1.33% | 1.49% | 2.17% | 1.57% | 1.47% | 1.60% | 1.43% |
Frequently Asked Questions
XLV and DGS have a correlation of 0.32, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DGS has higher volatility (7.30%) compared to XLV (4.90%). In terms of maximum drawdown, XLV dropped -39.17% vs DGS's -61.83%.
On 10-year performance, DGS leads with 10.14% vs 9.81% for XLV. On fees, XLV is cheaper at 0.08% per year. On volatility, XLV has been the lower-risk option at 4.90%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, DGS has performed better with a 10.14% return vs 9.81%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XLV is cheaper with a 0.08% expense ratio, compared with 0.58% for DGS.
DGS has the higher dividend yield at 3.20%, compared with 1.63% for XLV.
XLV is categorized as Health & Biotech Equities, while DGS is Emerging Markets Diversified. XLV tracks Health Care Select Sector Index, while DGS tracks WisdomTree Emerging Markets SmallCap Dividend Index. They also come from different issuers: State Street and WisdomTree. Their fees differ too: 0.08% for XLV and 0.58% for DGS.
DGS currently has the higher Sharpe Ratio (1.44 vs 0.97), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XLV and DGS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer